Special Issues
Diseases publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process.
The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue polices and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.
From Monitoring to Management: Addressing Challenges in Type 1 and Type 2 Diabetes Care
Deadline: 31 October 2026
The Future of Mental Health: Bridging the Translational Gap Between Mechanism, Practice, and Ethics
Deadline: 31 October 2026
Metabolic Disorders: Insights into Pathogenesis and Novel Therapeutic Strategies (2nd Edition)
Deadline: 30 November 2026
Towards Precision Treatment: Advances in the Diagnosis and Treatment of Heart Failure
Deadline: 30 November 2026
Advances in Melanoma: From Basic Research to Clinical Management, and Future Horizons Exploitation
Deadline: 31 December 2026
‘Rare Syndromes: Diagnosis and Treatment’ in 2024–2026
Deadline: 31 December 2026
Advances in Molecular Pathogenesis, Precision Medicine, and Artificial Intelligence in Hematologic Malignancies
Deadline: 31 December 2026
Immune-Mediated Thrombosis: Mechanisms, Vaccine Association, and Therapeutic Innovations
Deadline: 31 December 2026
Serum Uric Acid and Emerging Cardiometabolic Risk Markers in Primary Care: Multimorbidity and Real-World Evidence
Deadline: 31 December 2026
Molecular Biomarkers and Precision Medicine in Human Diseases: From Discovery to Clinical Application
Deadline: 31 January 2027
Cancer Inhibitory Receptors and Related Cancer Immunotherapy
Deadline: 28 February 2027
Functional Foods and Supplements: Special Focus on Mechanisms of Action and Potential Clinical Application
Deadline: 28 February 2027
of 3

